Picture of Diamyd Medical AB logo

DMYD B Diamyd Medical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Diamyd Medical Pauses Start Of Phase III Trial

Nov 30 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * DIAMYD MEDICAL PAUSES START OF PHASE III TRIAL
    * TO PAUSE START OF THE PRECISION MEDICINE PHASE III TRIAL
DIAGNODE-3 AND  START OF OTHER CLINICAL TRIALS WITH DIABETES
VACCINE DIAMYD
    * POTENTIAL PRESENCE OF A CONTAMINATION EARLY IN
MANUFACTURING
PROCESS OF CURRENT STUDY DRUG
    * WILL EVALAUTE ITS SPECIFIC REMOVAL BEFORE ADDITIONAL
CLINICAL
WORK IS CONDUCTED.

Source text for Eikon:  ID:nWkrWYfs0 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))

Recent news on Diamyd Medical AB

See all news